Researchers from Rensselaer Polytechnic Institute (RPI) and Albany Medical College were awarded a $3.3 million grant over five years by the National Cancer Institute to use artificial intelligence to improve targeted drug therapy in HER2-positive breast cancer treatment.
[Albany Medical College]